Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Non-aqueous composition having drug carried therein, and method for producing same

A composition, non-aqueous technology, applied in the directions of non-active ingredients medical preparations, active ingredients-containing medical preparations, drug delivery, etc., can solve the problems of time and cost, etc.

Inactive Publication Date: 2020-01-17
技术防卫株式会社
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, as a method of removing the water phase from the emulsion, when the method of freeze-drying the emulsion at minus tens of degrees Celsius proposed so far is adopted, it takes time and cost.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Non-aqueous composition having drug carried therein, and method for producing same
  • Non-aqueous composition having drug carried therein, and method for producing same
  • Non-aqueous composition having drug carried therein, and method for producing same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Example 1: loaded with prostaglandin E 1 of non-aqueous compositions (one of them)

[0036] Collect prostaglandin E in a 50 mL beaker 1 900 μg, medium-chain fatty acid triglyceride (ODO: manufactured by Nissin Oilio (Oillio) Co., Ltd., hereinafter the same) 900 mg, refined egg yolk lecithin (PC-98N: manufactured by キユーピー Corporation, hereinafter the same) 3.6 g, polysorbate (polysorbate) Sorbitate 80) 3.6g, propylene glycol 30g, by heating to 45°C in a water bath, dissolving and processing with a mixing mixer under nitrogen flow for about 10 minutes, to obtain the target prostaglandin E 1 non-aqueous composition (colorless transparent viscous liquid). Collect 200 mg of this viscous liquid into a test tube, dilute it 10 times with pure water, and shake it by hand for 1 minute to prepare a colorless, cloudy prostaglandin E-containing 1 fat emulsion (refer to Table 1, 2).

Embodiment 2

[0037] Example 2: Non-aqueous composition loaded with tocopheryl acetate

[0038] In a 50 mL beaker, 60 mg of tocopheryl acetate, 300 mg of medium-chain fatty acid triglyceride (ODO), 3 g of refined egg yolk lecithin (PL-100M: manufactured by キユーピー company, the same below) and 2.4 g of polysorbate (polysorbate 80) were collected in a 50 mL beaker. g, 30 g of propylene glycol, while being heated to 60° C. in a water bath, dissolve and process with a mixer for about 30 minutes to obtain the target non-aqueous composition (yellow transparent viscous liquid) loaded with tocopheryl acetate. Collect 200 mg of this viscous liquid into a test tube, dilute it 10 times with pure water, and shake it by hand for 1 minute to prepare a yellow, thin, turbid tocopheryl acetate-containing fat emulsion (see Tables 1 and 2).

Embodiment 3

[0039] Embodiment 3: non-aqueous compositions loaded with dexamethasone palmitate (one of them)

[0040] Collect 30 mg of dexamethasone palmitate, 300 mg of refined soybean oil, 3 g of refined egg yolk lecithin (PL-100M), 6 g of polysorbate (polysorbate 80), and 30 g of propylene glycol in a 50 mL beaker. 60° C. for about 15 minutes while dissolving with a mixer to obtain the target dexamethasone palmitate-loaded non-aqueous composition (pale yellow transparent viscous liquid). Collect 200 mg of this viscous liquid into a test tube, dilute it 10 times with pure water, and shake it by hand for 1 minute to prepare a colorless and transparent fat emulsion containing dexamethasone palmitate (see Tables 1 and 2).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
turbidityaaaaaaaaaa
Login to View More

Abstract

The present invention addresses the problem of providing: a non-aqueous composition having a drug carried therein, which can be prepared by mixing a drug-containing fat emulsion that can be used as aninjectable solution, an eye drop, a nasal spray, an inhalant and the like with an aqueous medium upon use without needing to produce a drug-containing fat emulsion in advance; and a method for producing the non-aqueous composition. The non-aqueous composition having a drug carried therein according to the present invention, which is a solution for the problem, is characterized in that componentsare dissolved in a polyhydric alcohol that serves as a water-soluble carrier in such a manner that the content of an oil or fat can be 0.05 to 250 mg / g, the ratio of the content of a poorly-water-soluble drug to the content of the oil or fat (i.e., (poorly-water-soluble drug) / (oil or fat)) can be 0.0001 to 50 by weight (provided that the total content of the poorly-water-soluble drug and the oil or fat is up to 300 mg / g) and the content of an emulsifying agent can be 20 to 500 mg / g.

Description

【Technical field】 [0001] The invention relates to a drug-loaded non-aqueous composition capable of preparing a drug-containing fat emulsion by mixing with an aqueous medium such as water for injection or physiological saline when used, and a preparation method thereof. 【Background technique】 [0002] Those skilled in the art are familiar with the fact that fat emulsions containing drugs, such as those containing steroids (dexamethasone palmitate) and those containing prostaglandins (PGE 1 ) and several emulsions headed by fat emulsions have been listed and widely used. However, among them, there is a limitation that storage in a cold place is required due to poor stability. [0003] As a method of improving the storage stability of a drug-containing fat emulsion, a method of removing the water phase from the emulsion and maintaining it in a dry state is known. However, as a method of removing the water phase from the emulsion, when the method of freeze-drying the emulsion ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/44A61K9/08A61K31/337A61K31/5575A61K31/573A61K47/10
CPCA61K31/337A61K31/5575A61K31/573A61K9/107A61K47/14A61K47/26A61K47/24A61K47/10A61K47/44A61K9/0019A61K9/06
Inventor 锅田喜一郎
Owner 技术防卫株式会社
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products